MeSH tree: C19.246.267
An international research group led by researchers from VUB-UZ Brussels and KU Leuven has demonstrated that a combined approach targeting both the immune system and insulin-producing beta cells can slow the progression of ...
Jul 14, 2026
0
3
New research presented at the International Society for Stem Cell Research (ISSCR) 2026 Annual Meeting explores an approach that could expand the potential of cell replacement therapy for type 1 diabetes by evaluating whether ...
Jul 10, 2026
0
13
T cells are an elite fighting force of the immune system, seeking out and destroying diseased cells. But in a prolonged campaign against a chronic condition—like a viral infection or cancer—the body needs a steady supply ...
Jul 1, 2026
0
17
A trial led by University of Pittsburgh researchers and published today in The Lancet Diabetes & Endocrinology adds nuance to the question of whether older human insulins are as effective as insulin analogs in low-resource ...
Jun 30, 2026
0
6
Type 1 diabetes is widely understood as an autoimmune disease, with the immune system attacking the insulin-producing beta cells of the pancreas. But two new studies suggest those cells may be more than passive victims. Together, ...
The autoimmunity associated with type 1 diabetes often begins in the first years of life, and the diagnosis of type 2 diabetes is rapidly rising among children and teens.
Jun 29, 2026
0
6
More children are getting diseases such as celiac disease, type 1 diabetes and inflammatory bowel disease (IBD) than before, research shows. IBD is a term for conditions like ulcerative colitis and Crohn's disease. These ...
Jun 29, 2026
0
6
Type 1 diabetes is an autoimmune disease in which the immune system attacks the insulin-producing beta cells of the pancreas. Despite advances in glycemic control and the development of new immunotherapies, there is still ...
Jun 23, 2026
0
4
The incidence of type 1 diabetes among teens in Puerto Rico more than doubled from 2009 to 2021 and remained elevated through 2024, with an average annual increase of 4.1%, according to a study presented at ENDO 2026, the ...
Jun 13, 2026
0
6
A group of researchers at the Medical University of South Carolina (MUSC) has recently developed a new stem cell therapy with a remarkable ability to reverse new-onset type 1 diabetes (T1D) in a mouse model of the disease. ...
Jun 7, 2026
0
25
